Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: more from street.com... they rate a hold.. but income rated a 5 of 5

more from street.com... they rate a hold.. but income rated a 5 of 5

posted on Mar 06, 2008 06:54AM

STOCK-AT-A-GLANCE

Below is a summary of the major fundamental and technical factors we consider when determining our

overall recommendation of PTSC shares. It is provided in order to give you a deeper understanding of our

rating methodology as well as to paint a more complete picture of a stock's strengths and weaknesses. It is

important to note, however, that these factors only tell part of the story. To gain an even more comprehensive

understanding of our stance on the stock, these factors must be assessed in combination with the stock’s

valuation. Please refer to our Valuation section on page 5 for further information.

FACTOR SCORE

Growth 3.5 out of 5 stars

Measures the growth of both the company's income statement and

cash flow. On this factor, PTSC has a growth score better than 60% of

the stocks we rate.

weak strong

Total Return 3.0 out of 5 stars

Measures the historical price movement of the stock. The stock

performance of this company has beaten 50% of the companies we

cover.

weak strong

Efficiency 4.0 out of 5 stars

Measures the strength and historic growth of a company's return on

invested capital. The company has generated more income per dollar of

capital than 70% of the companies we review.

weak strong

Price volatility 2.0 out of 5 stars

Measures the volatility of the company's stock price historically. The

stock is less volatile than 30% of the stocks we monitor.

weak strong

Solvency 4.0 out of 5 stars

Measures the solvency of the company based on several ratios. The

company is more solvent than 70% of the companies we analyze.

weak strong

Income 5.0 out of 5 stars

Measures dividend yield and payouts to shareholders. The company's

dividend is higher than 90% of the companies we track.

weak strong

THESTREET.COM RATINGS RESEARCH METHODOLOGY

TheStreet.com Ratings' stock model projects a stock's total return potential over a 12-month period including

both price appreciation and dividends. Our Buy, Hold or Sell ratings designate how we expect these stocks to

perform against a general benchmark of the equities market and interest rates. While our model is

quantitative, it utilizes both subjective and objective elements. For instance, subjective elements include

expected equities market returns, future interest rates, implied industry outlook and forecasted company

earnings. Objective elements include volatility of past operating revenues, financial strength, and company

cash flows.

Our model gauges the relationship between risk and reward in several ways, including: the pricing drawdown

as compared to potential profit volatility, i.e.how much one is willing to risk in order to earn profits; the level of

acceptable volatility for highly performing stocks; the current valuation as compared to projected earnings

growth; and the financial strength of the underlying company as compared to its stock's valuation as

compared to projected earnings growth; and the financial strength of the underlying company as compared

to its stock's performance. These and many more derived observations are then combined, ranked, weighted,

and scenario-tested to create a more complete analysis. The result is a systematic and disciplined method of

selecting stocks.

Share
New Message
Please login to post a reply